@FiercePharma: GSK, Merck tops at delivering meds to the poor. Report | Follow @FiercePharma
> Worker exposure to methylene chloride, a potential cause of cancer, has landed UCB Manufacturing in hot water with the Occupational Safety and Health Administration. And the drugmaker's Rochester, NY, plant may be in for more than $350,000 in fines. Report
> Dr. Reddy's Laboratories may be the biggest beneficiary among Indian generics makers as $157 billion of medicines--including Eli Lilly's Zyprexa--lose patent protection within five years, HDFC Securities said. Report
> The FDA will soon start posting online information about the year's food, drug and medical device recalls. Report
> Consolidated Pharmaceutical agreed to pay $250,000 in fines, never again own a business in Maryland and sell its long-dormant Baltimore-area penicillin-making site as part of a plea to criminal charges stemming from its abandonment of toxic chemicals there. Report
> Forest Laboratories and Merz Pharmaceuticals won the FDA nod for their extended-release dementia drug Namenda XR. Release
> APP Pharmaceuticals received FDA approval for its generic version of the Bristol-Myers Squibb anti-infective treatment Aztreonam. Report
Biotech News
@FierceBiotech: FDA experts unanimously reject Boehringer's female libido pill. Article | Follow @FierceBiotech
@JohnCFierce: Amylin laid off 60 staffers, including research workers. Wants to look 'outside' more. Article | Follow @JohnCFierce
> HHS report underscores big shift to foreign drug trials. Story
> Pain startup lands $43M round, option to sell for up to $228M. Item
> Ortho-McNeil inks twin diabetes pacts totaling $1B. Article
> Regulus pairs with Sanofi in $750M microRNA pact. Report
Biotech Research News
> UK plans £600 million biomedical facility. Report
> Pew names slate of outstanding young researchers. Article
> Novartis' MS blockbuster highlights potential of nature's drugs. News
> Gene therapy strategy cures Type 1 diabetes in mice. Article
> Cellceutix reports preclinical progress on cancer therapy. Story
Manufacturing News
> J&J's stock dips in wake of recall. Report
> Ryder gets patent for supply chain method. Story
> GS1, India develop tracking system for recalls. Article
> Big pharma sees opportunity in Russia. News
And Finally... A "rewritten" flu virus prompts an identical immune response in mice to a natural infection, meaning it could make a more effective vaccine than traditional options. Report